Kimberly-Clark stock (US4943681035): shares hover near 100 USD ahead of valuation focus

Kimberly-Clark shares were changing hands at around USD 100 on the Nasdaq on Friday, leaving the United States-based tissue and personal care producer broadly steady as investors assessed its recent volume trends, ongoing portfolio reshaping and income characteristics in the wider consumer staples universe, according to MarketBeat as of 05/29/2026.MarketBeat as of 05/29/2026

The stock traded at USD 100.14 on 05/29/2026 on Nasdaq under the ticker KMB, compared with a 52-week range of USD 92.42 to USD 144.30, underscoring a moderate recovery from its recent lows but still below last year’s peak levels, according to MarketBeat as of 05/29/2026.MarketBeat as of 05/29/2026 In Germany, the shares are also available via off-exchange venues such as Tradegate in euros, providing an additional access point for eurozone retail investors tracking U.S. consumer staples.

As of: 29.05.2026

By the editorial team - specialized in equity coverage.

Kimberly-Clark: core business model

Kimberly-Clark generates most of its revenue by developing and marketing branded tissue and personal care products such as diapers, paper towels and hygiene solutions to retail, professional and healthcare customers across global consumer markets.

Valuation metrics and multiples for Kimberly-Clark

With the share price around USD 100, investor attention on Friday has been largely centered on valuation markers such as earnings multiples, cash flow generation and dividend yield as typical reference points for a mature U.S. consumer staples issuer like Kimberly-Clark, particularly in comparison with peers in tissue and household products. According to MarketBeat as of 05/29/2026, Kimberly-Clark carries a consensus analyst rating of "Hold" and an average price target of about USD 114.93, suggesting that sell-side expectations assume a degree of upside from current trading levels but reflect a balanced risk-reward profile for the stock.MarketBeat as of 05/29/2026

The stock’s 52-week band from USD 92.42 to USD 144.30 points to significant fluctuations in the valuation investors have been willing to pay for the business over the past year, influenced by input cost dynamics, pricing power and volume trends in categories such as tissue and baby care, according to MarketBeat data as of 05/29/2026.MarketBeat as of 05/29/2026 Investor focus has also been shaped by management’s comments on growth and margins, including a recent indication that volume plus mix growth reached about 3% and that the company raised its global category growth outlook to 2.5% for fiscal 2026, according to a Zacks analysis referencing company commentary as of 05/2026.Zacks as of 05/2026 These factors, along with its established dividend track record and cash generation, are key components in how the market assesses Kimberly-Clark’s valuation within the consumer staples sector.

Conclusion

Kimberly-Clark’s share price around USD 100 on the Nasdaq and its positioning within a defensive consumer staples segment underscore how investors currently weigh its stable cash flows, dividend profile and recent volume-plus-mix improvements against a backdrop of cost pressures and competition. The valuation discussion on Friday is informed by the consensus "Hold" stance and price targets clustered above the present quote, while the trading range and category growth outlook help frame expectations for how the company might balance pricing, innovation and profitability over the coming quarters.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.